MoonLake Immunotherapeuti... (MLTX)
NASDAQ: MLTX
· Real-Time Price · USD
59.72
0.22 (0.37%)
At close: Sep 04, 2025, 3:59 PM
59.72
0.00%
After-hours: Sep 04, 2025, 04:10 PM EDT
0.37% (1D)
| Bid | 55.27 |
| Market Cap | 3.79B |
| Revenue (ttm) | 101.85K |
| Net Income (ttm) | -176.47M |
| EPS (ttm) | -2.79 |
| PE Ratio (ttm) | -21.41 |
| Forward PE | -14.64 |
| Analyst | Buy |
| Ask | 60 |
| Volume | 672,342 |
| Avg. Volume (20D) | 549,017.7 |
| Open | 59.52 |
| Previous Close | 59.50 |
| Day's Range | 56.80 - 59.97 |
| 52-Week Range | 31.42 - 61.87 |
| Beta | 1.27 |
About MLTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MLTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MLTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+17.95%
MoonLake Immunotherapeutics shares are trading hig...
Unlock content with
Pro Subscription
3 months ago
+5.51%
MoonLake Immunotherapeutics shares are trading higher following reports that Merck held talks to acquire the Swiss biotech company for over $3 billion.
